1854 Cisplatin plus oral vinorelbine as first line chemotherapy in patients with triple negative advanced breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(16)30804-8 ◽

2015 ◽

Vol 51 ◽

pp. S283

Author(s):

M. Moawad Abdel Wahab ◽

L. Ezz Elarab

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Triple Negative ◽

Advanced Breast ◽

Oral Vinorelbine ◽

Line Chemotherapy

Download Full-text

Abstract P1-14-01: Final results of NorBreast-231, a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel as first-line chemotherapy in patients with advanced breast cancer

10.1158/1538-7445.sabcs18-p1-14-01 ◽

2019 ◽

Author(s):

MS Aapro ◽

R Hegg ◽

M Ruiz Borrego ◽

E Staroslawska ◽

S Morales ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.08.485 ◽

2021 ◽

Vol 32 ◽

pp. S447

Author(s):

M.E. Cazzaniga ◽

N. Martinez Jañez ◽

B.D. Kukielka-Budny ◽

M. Ulanska ◽

H. Bourgeois ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Study ◽

Single Agent ◽

Advanced Breast ◽

Oral Vinorelbine ◽

Line Chemotherapy

Download Full-text

346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

European Journal of Cancer ◽

10.1016/0959-8049(95)95599-2 ◽

1995 ◽

Vol 31 ◽

pp. S75 ◽

Author(s):

R. Paridaens ◽

P. Bruning ◽

F. Calabresi ◽

A. Awada ◽

J.A. Roy ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)

Annals of Oncology ◽

10.1093/annonc/mdi056 ◽

2005 ◽

Vol 16 (2) ◽

pp. 253-258 ◽

Author(s):

L. Del Mastro ◽

F. Perrone ◽

L. Repetto ◽

L. Manzione ◽

V. Zagonel ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

Line Chemotherapy

Download Full-text

Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdf056 ◽

2002 ◽

Vol 13 (4) ◽

pp. 546-552 ◽

Author(s):

M. Venturini ◽

L. Del Mastro ◽

O. Garrone ◽

C. Angiolini ◽

M. Merlano ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Finding Study ◽

Dose Finding Study ◽

Line Chemotherapy

Download Full-text

Randomised Phase Ii Study Evaluating, As First-Line Chemotherapy, Weekly Oral Vinorelbine As a Single-Agent Versus Weekly Paclitaxel As a Single-Agent in Estrogen Receptor Positive, Her2-Negative Patients with Advanced Breast Cancer (Norbreast-231 Trial)

Annals of Oncology ◽

10.1093/annonc/mdu329.63 ◽

2014 ◽

Vol 25 ◽

pp. iv136

Author(s):

M. Aapro ◽

E. Staroslawska ◽

S. Morales ◽

M. Ruiz Borrego ◽

S. Cinieri ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Single Agent ◽

Oral Vinorelbine ◽

Estrogen Receptor Positive ◽

Line Chemotherapy

Download Full-text

Should paclitaxel be combined with epirubicin or carboplatin as first-line chemotherapy for advanced breast cancer?

Nature Clinical Practice Oncology ◽

10.1038/ncponc0079 ◽

2005 ◽

Vol 2 (2) ◽

pp. 80-81

Author(s):

Sudeep Gupta

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Line Chemotherapy

Download Full-text

Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study

Investigational New Drugs ◽

10.1007/bf00174161 ◽

1985 ◽

Vol 3 (2) ◽

pp. 139-148 ◽

Author(s):

H. T. Mouridsen ◽

Michael Cornbleet ◽

Robin Stuart-Harris ◽

Ian Smith ◽

Robert Coleman ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

European Study ◽

Line Chemotherapy

Download Full-text

Abstract OT3-02-04: Randomised phase II study evaluating, as first-line chemotherapy, single-agent oral vinorelbine administered with two different schedules in patients with hormone receptor positive, HER2-negative advanced breast cancer (TempoBreast-1 trial)

10.1158/1538-7445.sabcs15-ot3-02-04 ◽

2016 ◽

Author(s):

J De la Haba ◽

M Cazzaniga ◽

G Freyer ◽

L Costa ◽

E Petru ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Single Agent ◽

Oral Vinorelbine ◽

Hormone Receptor Positive ◽

Line Chemotherapy

Download Full-text

Phase II, multicentre study evaluating cisplatin (P), epirubicin (E) and vinorelbine (V) as first line chemotherapy (CHT) in advanced breast cancer (ABC): A new promise

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.761 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 761-761

Author(s):

S. Barni ◽

M. T. Ionta ◽

R. Labianca ◽

A. Zaniboni ◽

A. Ardizzoia ◽

...

Keyword(s):

Breast Cancer ◽

Multicentre Study ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

Line Chemotherapy

Download Full-text